Literature DB >> 6800841

Lymphokines: their role in lymphocyte responses. Properties of interleukin 1.

J J Oppenheim, B M Stadler, R P Siraganian, M Mage, B Mathieson.   

Abstract

Interleukin 1, or IL 1, otherwise known as lymphocyte-activating factor, is a macrophage-derived 12,000- to 15,000-dalton polypeptide. Isoelectric focusing of human IL 1 reveals three peaks at pI's of 5.2, 6.0 and 6.9 respectively. IL 1 can be depleted of lymphocyte-derived IL 2 by SP-Sephadex chromatography. IL 1 augments the mitogenic response of PNA- Lyt 1+ thymocytes, and promotes thymocyte helper functions and B cell antibody production. IL 1 induces stable E rosette formation and the production of lymphokines such as T cell growth factor (IL 2) by peripheral T lymphocytes. Others have shown that IL 1 or closely related factors also stimulate hypothalamic cells to induce fever; induce in vitro fibroblast growth, prostaglandin, and collagenase production; and stimulate hepatocytes to produce acute phase proteins such as serum amyloid A. Murine epidermal cells also produce a 15,000-dalton factor that is mitogenic for thymocytes and may be similar to IL 1. We have recently hybridized spleen cells from mice sensitized with partially purified human IL 1 with a myeloma cell line. Clones have been isolated that produce supernatants that partially inhibit the thymocyte proliferative response to IL 1 but not the T cell growth factor activity of IL 2. Should these hybridoma products prove to be monoclonal anti-IL 1 antibodies, they will facilitate the further purification and characterization of IL 1.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6800841

Source DB:  PubMed          Journal:  Fed Proc        ISSN: 0014-9446


  36 in total

1.  Stimulation of in vitro human skin collagenase expression by platelet-derived growth factor.

Authors:  E A Bauer; T W Cooper; J S Huang; J Altman; T F Deuel
Journal:  Proc Natl Acad Sci U S A       Date:  1985-06       Impact factor: 11.205

2.  Presence of epidermal-derived thymocyte activating factor/interleukin 1 in normal human stratum corneum.

Authors:  L C Gahring; A Buckley; R A Daynes
Journal:  J Clin Invest       Date:  1985-10       Impact factor: 14.808

3.  Alpha 2-macroglobulin secretion enhanced in rat hepatocytes by partially characterized factor from Kupffer cells.

Authors:  Y Hirata; H Ishibashi; H Kimura; K Hayashida; M Nagano; H Okubo
Journal:  Inflammation       Date:  1985-06       Impact factor: 4.092

Review 4.  Bronchoalveolar T lymphocytes and pulmonary sarcoidosis.

Authors:  G W Hunninghake
Journal:  Clin Rev Allergy       Date:  1985-05

5.  Acute phase response of serum amyloid A protein and C reactive protein to the common cold and influenza.

Authors:  J T Whicher; R E Chambers; J Higginson; L Nashef; P G Higgins
Journal:  J Clin Pathol       Date:  1985-03       Impact factor: 3.411

6.  Processing of Bacillus subtilis peptidoglycan by a mouse macrophage cell line.

Authors:  M W Vermeulen; G R Gray
Journal:  Infect Immun       Date:  1984-11       Impact factor: 3.441

7.  Involvement of inflammatory leukocytes in hepatic induction of T-kininogen in rat.

Authors:  N Itoh; T Toyohama; H Okamoto; H Kawano; T Mayumi; T Hama
Journal:  Inflammation       Date:  1987-09       Impact factor: 4.092

8.  In vitro modulation of keratinocyte-derived interleukin-1 alpha (IL-1 alpha) and peripheral blood mononuclear cell-derived IL-1 beta release in response to cutaneous commensal microorganisms.

Authors:  C E Walters; E Ingham; E A Eady; J H Cove; J N Kearney; W J Cunliffe
Journal:  Infect Immun       Date:  1995-04       Impact factor: 3.441

9.  Spontaneous production of thymocyte-activating factor by human gingival fibroblasts and its autoregulatory effect on their proliferation.

Authors:  Y Ohmori; S Hanazawa; S Amano; T Miyoshi; K Hirose; S Kitano
Journal:  Infect Immun       Date:  1987-04       Impact factor: 3.441

10.  Characterization of soluble factors that induce the cytolytic activity and the expression of T cell growth factor receptors of a T cell hybrid.

Authors:  F Erard; P Corthesy; K A Smith; W Fiers; A Conzelmann; M Nabholz
Journal:  J Exp Med       Date:  1984-08-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.